Navigation Links

ACEA Biosciences Presents Efficacy and Safety Data From AC0010 Phase I/II Clinical Trial for Treatment of Advanced Non-Small Cell Lung Cancer at the WCLC 2016 Conference

San Diego (PRWEB) December 07, 2016 ACEA Biosciences, Inc. presented today updated efficacy and safety data from its phase I/II dose escalation and expansion clinical trial for its lead drug candidate, AC0010, at the World Conference on Lung Cancer (WCLC) 2016 in Vienna, Austria. The purpose... [Comments]

Blood-Based Molecular Testing For Pancreatic Cancer Patients

McLean, VA (PRWEB) December 07, 2016 A new study published in the just-published "Oncotarget" peer-reviewed medical journal has concluded that “in the setting of previously treated, advanced pancreatic cancer, liquid biopsies are not yet an adequate substitute for tissue biopsies. F... [Comments]

Huffman Engineering Is Wonderware Certified System Integrator Partner

Lincoln, NE (PRWEB) December 07, 2016 Huffman Engineering, Inc. , a leader in control systems integration, today announced that it has become a Wonderware Certified System Integrator Partner. Huffman Engineering is the only Nebraska-based company recognized as a Wonderware System Integrator... [Comments]

Neogen names Kephart as chief science officer

LANSING, Mich. , Dec. 7, 2016 Neogen Corporation (NASDAQ: NEOG ) announced today it has named Dr. Dan Kephart as its chief science officer — a new position for the company. Kephart will assume his responsibilities at Neogen effective Jan. 1. Kephart has served as research and development director for the agribusiness unit of Thermo Fisher Scientific, as well as animal he... [Comments]

OncoQuest Initiates Commercial Scale Oregovomab Manufacturing Program for Treatment of Ovarian Cancer

EDMONTON , Dec. 7, 2016 /PRNewswire/ - OncoQuest Inc. ("OncoQuest"), a biopharmaceutical company focused on the development and commercialization of immunotherapeutic products for the treatment of cancer, today announced that it has entered into an Antibody Manufacturing Development Program with Cytovance Biologics ( Oklahoma City, OK , USA) for its oregovomab antibody product. Supported by... [Comments]

Zenith Capital Corp. Announces Annual and Special Meeting Webcast Details

CALGARY , Dec. 7, 2016 /PRNewswire/ - Zenith Capital Corp. ("Zenith" or the "Company") announces webcast details for a corporate update that will be presented at the Company's Annual and Special Meeting. The Zenith Annual and Special Meeting of Shareholders will take place on Thursday, December 15, 2016 at Mount Royal University, Ross Glenn Hall (Room EC1040), 4825 Mount Royal G... [Comments]

Nordion and General Atomics Welcome US National Nuclear Security Administration Phase II Funding for New, Reliable Source of Molybdenum-99

OTTAWA, Ontario , Dec. 7, 2016  Nordion, a standalone business of Sterigenics International, in partnership with General Atomics (GA), welcome today's award by the United States Department of Energy's (DOE) National Nuclear Security Administration (NNSA) of the Phase II cooperative agreement funding to GA to complete its project with Nordion and the University of Missouri... [Comments]

Biocom Applauds Passage of 21st Century Cures Legislation

SAN DIEGO , Dec. 7, 2016  Biocom, the association for the California life science community, issued the statement below following passage of 21 st Century Cures legislation in Congress. The bill passed in the House on November 30 by a 392-26 vote and in the Senate on December 7 by a 94-5 vote. This statement may be attributed to Joe Panetta , president & CEO of B... [Comments]

Acrylic Processing Aid Market Worth 1,173.6 Million USD by 2026

PUNE, India , December 8, 2016 The report "Acrylic Processing Aid Market by Polymer Type (PVC), Fabrication Process (Extrusion, Injection Molding), End-Use Industry (Building & Construction, Packaging, Automotive, Consumer Goods) - Global Forecast to 2026", published by MarketsandMarkets, the global market size was USD 645.4 Million in 2016, and is projected to... [Comments]

Vyriad Appoints Alvin E. McQuinn to Board of Directors

ROCHESTER, Minn. , Dec. 7, 2016  Vyriad Inc. announced today the appointment of Alvin E. McQuinn to the company's Board of Directors. "We are delighted to welcome Al to Vyriad's board as we build our business and develop our oncolytic viruses as the next generation of precision medicines for cancer therapy," said Stephen Russell , MD, PhD, CEO of Vyriad. "Al and his w... [Comments]

(Date:12/6/2016)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) (the "Company") ... million principal amount of its 1.414% senior unsecured notes due ... unsecured notes due 2026. The closing of ... to the satisfaction of customary closing conditions.  The notes will ... The Company intends to use the net proceeds from ...
(Date:12/2/2016)... Dec. 1, 2016   SoftServe , a ... BioLock , an electrocardiogram (ECG) biosensor analysis system ... key IoT asset. The smart system ensures device-to-device ... steering wheel and mobile devices to easily ,recognize, ... As vehicle technology advances, so too must ...
(Date:11/29/2016)... Nearly one billion matches per second with DERMALOG,s high-speed AFIS    ... ... DERMALOG is Germany's largest Multi-Biometric supplier: The company's Fingerprint ... ... Multi-Biometric supplier: The company's Fingerprint Identification System is part of an efficient ...
Breaking Biology News(10 mins):
... The Staccato Application Series are a ... designed to provide fast and reliable ... proven and robust "automation-friendly" building blocks, ... that cost less than conventional approaches, ...
... 2-Methyl-3,5,7,8-tetrahydrothiopyrano[4,3-d]pyrimidine-4-one White solid. PROTECT ... brain-permeable and water soluble pyrimidinone compound that ... -competitive inhibitor of PARP (IC 50 ... rhPARP1 and rmPARP2, respectively) with little activity ...
... used to screen blots of mini format (8 ... up to 40 different antibodies or sera without ... apparatus includes a base plate, 2 separate, detachable ... x 7 cm membranes, and gaskets and clamps ...
Biology Products:
(Date:12/6/2016)... NY (PRWEB) , ... December 06, 2016 , ... ... integrator of custom industrial automation and IT solutions, today announced the company has ... has reliably delivered professionally executed automation and control systems integration services to leading ...
(Date:12/6/2016)... PHOENIX and SAN DIEGO ... (OTCQB:CELZ) announced the appointment of Santosh Kesari , ... Board. Dr. Kesari will leverage his experience in neurology and ... its adult stem cell for treatment of stroke. The AmnioStem ... amniotic fluid, which has previously shown therapeutic activity in ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... on discovery and development of precision treatments for neurodegenerative diseases, today announced ... disease (AD) inhibited the direct neurotoxic effect of prion-like forms of Amyloid ...
(Date:12/5/2016)... , Dec 5, 2016 Research ... "Biomarkers - Technologies, Markets and Companies" to their offering. ... , , ... and their discovery using various -omics technologies such as proteomics and ... and new tests are also based on biomarker. Currently ...
Breaking Biology Technology: